Table 2.
17 significant metabolic subpathways in pancreatic cancer
| Pathway ID | Pathway name | Ann molecule ratio | Ann bg ratio | P value | FDR |
| path:00564_1 | Glycerophospholipid metabolism | 9/378 | 47/25051 | 3.03E-08 | 5.15E-07 |
| path:00330_1 | Arginine and proline metabolism | 5/378 | 18/25051 | 5.55E-06 | 4.72E-05 |
| path:00020_1 | Citrate cycle (TCA cycle) | 3/378 | 9/25051 | 0.000267613 | 0.001516472 |
| path:00630_1 | Glyoxylate and dicarboxylate metabolism | 3/378 | 11/25051 | 0.000513985 | 0.002184435 |
| path:00140_4 | Steroid hormone biosynthesis | 4/378 | 32/25051 | 0.001313707 | 0.003783719 |
| path:00430_1 | Taurine and hypotaurine metabolism | 2/378 | 4/25051 | 0.00133543 | 0.003783719 |
| path:00061_3 | Fatty acid biosynthesis | 2/378 | 5/25051 | 0.002203499 | 0.004682436 |
| path:00650_1 | Butanoate metabolism | 2/378 | 5/25051 | 0.002203499 | 0.004682436 |
| path:00565_3 | Ether lipid metabolism | 3/378 | 21/25051 | 0.003704522 | 0.00699743 |
| path:00260_2 | Glycine, serine and threonine metabolism | 2/378 | 7/25051 | 0.004535597 | 0.007455604 |
| path:00140_7 | Steroid hormone biosynthesis | 3/378 | 23/25051 | 0.004824214 | 0.007455604 |
| path:00230_1 | Purine metabolism | 4/378 | 58/25051 | 0.011412618 | 0.016167876 |
| path:00480_1 | Glutathione metabolism | 3/378 | 38/25051 | 0.019466435 | 0.025456107 |
| path:00230_2 | Purine metabolism | 3/378 | 43/25051 | 0.026957207 | 0.032733751 |
| path:00071_1 | Fatty acid metabolism | 2/378 | 19/25051 | 0.032785866 | 0.037157315 |
| path:00240_1 | Pyrimidine metabolism | 2/378 | 48/25051 | 0.163441722 | 0.17365683 |
| path:00310_1 | Lysine degradation | 1/378 | 21/25051 | 0.27342756 | 0.27342756 |
FDR: False discovery rate.